Bevacizumab

A monoclonal antibody directed against human Vascular Endothelial Growth Factor (VEGF), a protein that stimulates angiogenesis, and prevents VEGF from binding to its receptors, causing inhibition of angiogenesis. (NCI)

Chemwatch helps thousands of organisations manage chemical safety. Book a free demo to see how.
Book a Demo →